期刊文献+

手术辅助化疗与单纯手术切除治疗结直肠癌合并肝转移效果比较 被引量:2

Surgical Resection with or without Adjuvant Chemotherapy for Colorectal Cancer with Liver Metastasis
原文传递
导出
摘要 为比较结直肠癌合并肝转移患者采用单纯手术切除与手术辅助化疗两种治疗方式的临床效果,回顾性分析56例结直肠癌合并肝转移患者的治疗结果,其中采取单纯手术切除治疗19例(对照组),采取手术辅助化疗治疗37例(观察组)。结果显示,通过治疗后1~3年的随访,观察组比对照组患者生存率明显提高,肿瘤复发控制情况更好。结果表明,手术辅助化疗可提高结直肠癌合并肝转移患者的术后生存率,降低复发率,化疗方案安全可靠。 In order to compare the clinical effect of surgical resection with or without adjuvant chemothera-py for colorectal cancer with liver metastasis in patients with colorectal cancer, a retrospective study was conducted among 56 cases of colorectal cancer with liver metastasis,which 19 cases received surgical resec-tion were selected as the controls, 37 cases received additional adjuvant chemotherapy as observation group. The results showed that after a 1-3 year follow-up, the survival rate of patients got improved signif-icantly in observation group than in the controls and tumor recurrence were better controlled. It is conclu-ded that surgical resection with adjuvant chemotherapy can improve the survival rate of patients with color-ectal cancer with liver metastasis, lower the recurrence rate, and chemotherapy regimen is safe and reliable.
作者 夏卿
出处 《中国肛肠病杂志》 2013年第3期15-16,共2页 Chinese Journal of Coloproctology
关键词 结直肠癌 肝转移 手术 化疗 Colorectal cancer Liver metastases Surgery Chemotherapy
  • 相关文献

参考文献5

二级参考文献56

  • 1赵平,王成锋,李玉升,李槐.结直肠癌肝转移仍应积极治疗[J].中华医学杂志,2005,85(30):2094-2096. 被引量:17
  • 2刘展,汪晓东,李立.结直肠外科快速流程内容及依据[J].中国普外基础与临床杂志,2007,14(4):469-473. 被引量:21
  • 3汪晓东,李立.结直肠肿瘤多学科协作诊治模式的数据体系构建与运作策略[J].中国普外基础与临床杂志,2007,14(4):474-476. 被引量:10
  • 4Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liv er metastases from colorectal cancer (EORTC Intergroup trial 40983 ) : a randomised controlled trial. Lancet, 2008, 371 ( 9617 ) : 1007-1016.
  • 5Rubbia-Brandt L, Audard V, Sartoretti P, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol, 2004, 15 (3) : 460-466.
  • 6Fernandez FG, Ritter J, Goodwin JW, et al. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coil Surg, 2005, 200 (6) :845- 853.
  • 7Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol, 2006, 24( 13 ) : 2065-2072.
  • 8Benoist S, Breuquet A, Penna C, et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure. J Clin Oncol, 2006, 24(24) :3939-3945.
  • 9Petrelli NJ. Perioperative or adjuvant therapy for resectahle colorectal hepatic metastases. J Clin Oncol, 2008, 26(30) :4862-4863.
  • 10Mitry E, Fields AL, Bleiberg H, et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol, 2008, 26 (30) :4906-4911.

共引文献12

同被引文献18

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部